These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2806237)

  • 21. Conformation of the trypanocidal pharmaceutical suramin in its free and bound forms: transferred nuclear overhauser studies.
    Polenova T; Iwashita T; Palmer AG; McDermott AE
    Biochemistry; 1997 Nov; 36(46):14202-17. PubMed ID: 9369494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The interaction of the phosphonate analogue of 3-phospho-D-glycerate with phosphoglycerate kinase.
    Orr GA; Knowles JR
    Biochem J; 1974 Sep; 141(3):721-3. PubMed ID: 4463959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Highly potent bisphosphonate ligands for phosphoglycerate kinase.
    Jakeman DL; Ivory AJ; Williamson MP; Blackburn GM
    J Med Chem; 1998 Nov; 41(23):4439-52. PubMed ID: 9804684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetic, binding, and NMR studies of perdeuterated yeast phosphoglycerate kinase and its interactions with substrates.
    Shibata CG; Gregory JD; Gerhardt BS; Serpersu EH
    Arch Biochem Biophys; 1995 May; 319(1):204-10. PubMed ID: 7771785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The roles of ATP4- and Mg2+ in control steps of phosphoglycerate kinase.
    Fairbrother WJ; Graham HC; Williams RJ
    Eur J Biochem; 1990 Jun; 190(2):407-14. PubMed ID: 2194802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modelling of substrate binding to 3-phosphoglycerate kinase with analogues of 3-phosphoglycerate.
    Vas M
    Eur J Biochem; 1990 Dec; 194(2):639-45. PubMed ID: 2269289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The roles of ADP2- and Mg2+ in control steps of phosphoglycerate kinase.
    Graham HC; Williams RJ
    Eur J Biochem; 1991 Apr; 197(1):81-91. PubMed ID: 2015827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Product inhibition studies of yeast phosphoglycerate kinase evaluating properties of multiple substrate binding sites.
    Schierbeck B; Larsson-Raźnikiewicz M
    Biochim Biophys Acta; 1979 May; 568(1):195-204. PubMed ID: 375985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of phosphoglycerate kinase by salicylates.
    Larsson-Raźnikiewicz M; Wiksell E
    Biochim Biophys Acta; 1978 Mar; 523(1):94-100. PubMed ID: 343818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age-related modifications in rat cardiac phosphoglycerate kinase. Rejuvenation of the old enzyme by unfolding-refolding.
    Zúñiga A; Gafni A
    Biochim Biophys Acta; 1988 Jun; 955(1):50-7. PubMed ID: 3382671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 31P NMR studies of enzyme-bound substrate complexes of yeast 3-phosphoglycerate kinase. 1. Effects of sulfate and pH. Mg(II) affinity at the two ATP sites.
    Ray BD; Rao BD
    Biochemistry; 1988 Jul; 27(15):5574-8. PubMed ID: 3052580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphoglycerate kinase from yeast synthesizes guanosine 5'-tetraphosphate.
    García-Díaz M; Canales J; Sillero MA; Sillero A; Cameselle JC
    Biochem Int; 1989 Dec; 19(6):1253-64. PubMed ID: 2635862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of ATP analogs with yeast 3-phosphoglycerate kinase. Affinity labeling of the hinge region.
    Pineda T; Kwon OS; Serpersu EH; Churchich JE
    Eur J Biochem; 1993 Mar; 212(3):719-26. PubMed ID: 8462545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation and inhibition of phosphoglycerate kinase by sulphate ion.
    Khamis MM; Larsson-Raźnikiewicz M
    Biochim Biophys Acta; 1981 Jan; 657(1):190-4. PubMed ID: 7011400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterisation of yeast phosphoglycerate kinase modified by mutagenesis at residue 21.
    Walker PA; Joâo HC; Littlechild JA; Williams RJ; Watson HC
    Eur J Biochem; 1992 Jul; 207(1):29-37. PubMed ID: 1628654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel bisphosphonate inhibitors of phosphoglycerate kinase.
    Caplan NA; Pogson CI; Hayes DJ; Blackburn GM
    Bioorg Med Chem Lett; 1998 Mar; 8(5):515-20. PubMed ID: 9871609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the structure and properties of the His 62-->Ala and Arg 38-->Ala mutants of yeast phosphoglycerate kinase: an investigation of the catalytic and activatory sites by site-directed mutagenesis and NMR.
    Sherman MA; Fairbrother WJ; Mas MT
    Protein Sci; 1992 Jun; 1(6):752-60. PubMed ID: 1304916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crystallographic and thiol-reactivity studies on the complex of pig muscle phosphoglycerate kinase with ATP analogues: correlation between nucleotide binding mode and helix flexibility.
    Kovári Z; Flachner B; Náray-Szabó G; Vas M
    Biochemistry; 2002 Jul; 41(28):8796-806. PubMed ID: 12102622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 19F NMR measurements of the rotational mobility of proteins in vivo.
    Williams SP; Haggie PM; Brindle KM
    Biophys J; 1997 Jan; 72(1):490-8. PubMed ID: 8994636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Photochemically induced dynamic nuclear polarization NMR study of yeast and horse muscle phosphoglycerate kinase.
    Scheffler JE; Cohn M
    Biochemistry; 1986 Jul; 25(13):3788-96. PubMed ID: 3527256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.